Essential Guide to End‑Stage Kidney Disease (ESRD): Symptoms, Causes, Treatment & Outlook

Read on to discover what end‑stage kidney disease (ESRD) is, its warning signs, underlying causes, treatment options, and what to expect.

End‑stage kidney disease, also called end‑stage renal disease, is reached when the kidneys operate at less than 15 % of their normal filtering capacity. At this point they may be barely functional or cease functioning altogether.

Kidney disease typically progresses slowly. How long each stage lasts depends heavily on how the condition is managed—especially diet, medication, and whether dialysis is introduced.

In most people chronic kidney disease does not advance to the final stage until 10‑20 years after the initial diagnosis.

What are the five stages of renal disease?

ESRD represents stage 5 of chronic kidney disease, which is classified by the estimated glomerular filtration rate (eGFR). Common early signs include:

• Decreased urine output or inability to urinate
• Persistent fatigue and general malaise
• Headaches
• Unexplained weight loss
• Loss of appetite, nausea, vomiting
• Dry, itchy skin and changes in skin color
• Bone pain
• Confusion or difficulty concentrating

Additional symptoms may appear:

• Easy bruising or frequent nosebleeds
• Numbness in the hands or feet
• Bad breath
• Excessive thirst or frequent hiccups
• Irregular menstrual cycles
• Sleep disturbances such as sleep apnea or restless‑leg syndrome
• Reduced libido or impotence
• Swelling (edema), especially in the legs and hands

Seek medical attention promptly if any symptom interferes with daily life—particularly an inability to urinate, frequent vomiting, severe weakness, or sleep disruption.

Modern therapies have extended life expectancy for people with ESRD, yet the condition remains serious. Even with dialysis, mortality within two years ranges from 20 % to 50 %, and outcomes are poorer for Black patients compared with White patients.

Most deaths are linked to hyperkalemia (high potassium) or other complications. In the United States, the five‑year survival rate for dialysis patients is about 35 %; it drops to roughly 25 % for those who also have diabetes.

The prognosis largely depends on the treatment plan. Dialysis can be performed in a center or at home, and portable machines now allow many patients to maintain a relatively normal routine.

Kidney transplantation offers an even higher success rate. About 97 % of transplanted kidneys function well one year after surgery, and most recipients enjoy a dramatically improved quality of life when they follow post‑transplant dietary and lifestyle recommendations.

If you feel discouraged by the lifestyle adjustments required for dialysis or transplant care, consider professional counseling and lean on supportive family and friends. Maintaining emotional well‑being is essential for preserving a high quality of life.

Most kidney diseases damage the nephrons—the tiny filtering units in the kidneys—leading to reduced blood filtration and eventually ESRD. The two most common culprits are diabetes and hypertension.

In diabetes, persistent high blood glucose injures nephrons. In hypertension, elevated pressure damages the delicate vessels that supply the kidneys, impairing filtration.

Other contributors to ESRD include:

• Long‑term urinary tract obstruction from kidney stones, an enlarged prostate, or certain cancers
• Glomerulonephritis (inflammation of the kidney’s filtering structures)
• Vesicoureteral reflux (urine flowing backward into the kidneys)
• Congenital kidney abnormalities

People with the following risk factors are more likely to develop ESRD:

• Diabetes
• High blood pressure
• Family history of ESRD

Having any chronic kidney condition also raises risk, such as:

• Polycystic kidney disease (PKD)
• Alport syndrome
• Interstitial nephritis
• Pyelonephritis
• Autoimmune disorders like lupus

Doctors confirm ESRD through a physical exam and a series of kidney‑function tests, including:

• Urinalysis: Detects protein or blood in the urine, indicating impaired filtration.
• Serum creatinine test: Measures creatinine levels in the blood; elevated levels suggest reduced kidney clearance.
• Blood urea nitrogen (BUN) test: Assesses nitrogen waste concentration in the bloodstream.
• Estimated glomerular filtration rate (eGFR): Calculates how efficiently the kidneys filter waste.

The primary treatments for ESRD are dialysis or kidney transplantation; lifestyle modifications and medications may also play supportive roles.

Dialysis

Two main dialysis modalities are available:

• Hemodialysis: Blood is circulated through an external machine that removes waste using a dialysate solution, then returns the cleansed blood to the body. Typical schedules involve three sessions per week, each lasting three to four hours.
• Peritoneal dialysis: A sterile solution is infused into the abdominal cavity, where it absorbs waste before being drained via a catheter. This method can be performed at home, often overnight, after proper training.

Kidney transplant

Transplant surgery replaces the diseased kidney with a healthy donor organ. Only one functional kidney is needed, so many donors are living individuals who give one kidney while retaining the other. According to the National Kidney Foundation, more than 25,000 kidney transplants were performed in the United States in 2022.

Medications

Effective control of diabetes and hypertension is critical for preventing or slowing ESRD. Angiotensin‑converting enzyme inhibitors (ACE inhibitors) and angiotensin‑receptor blockers (ARBs) are commonly prescribed for both conditions.

Finerenone (brand name Kerendia) has been shown to lower the risk of sustained eGFR decline, progression to ESRD, cardiovascular death, non‑fatal myocardial infarction, and heart‑failure hospitalization in adults with chronic kidney disease linked to type 2 diabetes.

Vaccinations

Vaccines can reduce the likelihood of serious infections in people with ESRD. Recommended immunizations include influenza, tetanus, pneumococcal disease, hepatitis B, and human papillomavirus (for those under 26 years old).

Lifestyle changes

Fluid balance is crucial; rapid weight fluctuations often signal fluid retention. Many patients need to increase calories while moderating protein intake. A diet low in sodium, potassium, phosphorus, and other electrolytes—combined with fluid restriction—helps control symptoms.

Foods high in sodium or potassium to limit include:

• Bananas, tomatoes, oranges, avocado
• Chocolate, nuts, peanut butter
• Spinach, soy or teriyaki sauces, salad dressings
• Canned goods, processed or instant meals
• Cold cuts, hot dogs, bagels

Targeted vitamin and mineral supplements (e.g., calcium, vitamin C, vitamin D, iron) may support overall health, but dosing should be individualized by a physician or renal dietitian.

Potential complications of ESRD range from common to severe:

• Skin infections, heightened infection risk, electrolyte disturbances, bone and joint pain, weak bones, nerve damage, fluctuating blood glucose

Less common but serious complications include liver failure, cardiovascular disease, fluid accumulation around the lungs, hyperparathyroidism, malnutrition, anemia, gastrointestinal bleeding, cognitive impairment, seizures, joint disorders, and fractures.

Can you recover from end‑stage kidney disease?

While ESRD is not reversible, appropriate treatment can enable many people to live for many years. Maintaining a balanced diet, controlling blood pressure and blood sugar, and staying at a healthy weight are essential. A registered dietitian can craft a personalized meal plan, and a nephrologist will oversee medications to avoid further kidney injury and to monitor for complications.

How can ESRD be prevented?

In some cases ESRD cannot be avoided, but strict control of blood glucose and blood pressure dramatically lowers risk. Prompt medical evaluation of any concerning symptom can lead to early detection and intervention, potentially slowing or halting disease progression.

How long does it take to progress from stage 4 to stage 5?

A 2018 study reported median times of nearly eight years in stage 3a, five years in stage 3b, 4.2 years in stage 4, and less than one year in stage 5. Once eGFR falls to 15 % or less, kidney function is severely compromised. Treatment—including dietary measures and dialysis—can significantly extend survival, even though the condition remains life‑threatening.